Tert-butyl 3-oxopiperazine-1-carboxylate → HCID 86586605, compound
Reaction equation
[Cl:1][C:2]1[N:7]=[CH:6][N:5]=[C:4]([N:8]2[CH2:15][CH2:14][C:11]3([O:13][CH2:12]3)[CH2:10][CH2:9]2)[CH:3]=1.[C:16]([O:20][C:21]([N:23]1[CH2:28][CH2:27][NH:26][C:25](=[O:29])[CH2:24]1)=[O:22])([CH3:19])([CH3:18])[CH3:17].CC(C)([O-])C.[K+]>C(O)(C)(C)C>[C:16]([O:20][C:21]([N:23]1[CH2:28][CH2:27][N:26]([CH2:12][C:11]2([OH:13])[CH2:14][CH2:15][N:8]([C:4]3[CH:3]=[C:2]([Cl:1])[N:7]=[CH:6][N:5]=3)[CH2:9][CH2:10]2)[C:25](=[O:29])[CH2:24]1)=[O:22])([CH3:19])([CH3:17])[CH3:18]Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 80 °C
Procedure
To a solution of 6-(6-chloropyrimidine-4-yl)-1-oxa-6-azaspiro[2,5]octane (4.00 g) and 4-(tert-butoxycarbonyl)-2-piperazinone (3.38 g) in tert-butylalcohol (50 ml) was added potassium tert-butoxide (0.57 g), and the mixture was stirred at 80° C. overnight. The reaction solution was concentrated, and the residue was diluted with ethyl acetate (100 ml), washed with 0.5N hydrochloric acid and saturated brine, dried and concentrated. The residue was purified with silica gel column chromatography (eluent: ethyl acetate) and crystallized from a mixture of ethyl acetate and diethylether to give colorless crystals of 4-(tert-butoxycarbonyl)-1-[1-(6-chloro-4-pyrimidinyl)-4-hydroxypiperidin-4-ylmethyl]piperazin-2-one (5.51 g).
Workup
- concentrationThe reaction solution was concentrated
- additionthe residue was diluted with ethyl acetate (100 ml)
- washwashed with 0.5N hydrochloric acid and saturated brine
- customdried
- concentrationconcentrated
- customThe residue was purified with silica gel column chromatography (eluent: ethyl acetate)
- customcrystallized from a mixture of ethyl acetate and diethylether
Sources & evidence
- ORD record
- ord-63bd9e7e9f344921a7a7db7946648363
- Source dataset
- uspto-grants-2004_01
- Patent number
- US06680312B2
Reaction notes
Loading…